Prelude Therapeutics
PRLD
PRLD
55 hedge funds and large institutions have $176M invested in Prelude Therapeutics in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 25 increasing their positions, 9 reducing their positions, and 14 closing their positions.
Holders
55
Holders Change
+1
Holders Change %
+1.85%
% of All Funds
0.87%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
25
Reduced
9
Closed
14
Calls
$2K
Puts
$5K
Net Calls
-$3K
Net Calls Change
-$3K
Top Buyers
| 1 |
BC
1
Boxer Capital
San Diego,
California
|
$11.2M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$26.7M |
| 3 |
EC
3
EcoR1 Capital
San Francisco,
California
|
$5.21M |
| 4 |
O
4
OrbiMed
New York
|
$49.1M |
| 5 |
5
T. Rowe Price Associates
Baltimore,
Maryland
|
$4.87M |
